← Leaderboards
Robert F Kalejta
University Of Wisconsin-Madison
$11,761,648
Attributed
$11,761,648
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,761,648 · 7
By mechanism
R01$11,040,825 · 5
R21$426,823 · 1
R56$294,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Christopher Gelbmann$84,299
Others in their field
Top investigators on “Cytomegalovirus”
- Constance Ann Benson · University Of California, San Diego$154,530,762
- Curtis L Meinert · Johns Hopkins University$72,267,482
- Louis J. Picker · Oregon Health And Science University$67,787,971
- Robert Turner Schooley · University Of Colorado Denver$42,307,156
- Dan H. Barouch · Fred Hutchinson Cancer Center$34,316,808
- Jay A Nelson · Oregon Health & Science University$28,085,685
Research focus
CytomegalovirusVirusMediatingViralLytic PhaseCellsProteinsInfectionCardiovascular DiseasesAntiviral AgentsPathogenLyticMalignant NeoplasmsCongenital AbnormalityTranscription FactorGene ExpressionGenomeCytomegalovirus InfectionsGenetic TranscriptionPathway InteractionsPublishingPersonsAcquired Immunodeficiency SyndromeOrgan Transplantation
Grant awards (35)
Transcriptional Control of Human Cytomegalovirus Latency$442,788
R01 · FY2025 · AI · contact PI
Transcriptional Control of Human Cytomegalovirus Latency$453,180
R01 · FY2024 · AI · contact PI
Transcriptional Control of Human Cytomegalovirus Latency$369,780
R01 · FY2022 · AI · contact PI
Evading innate immunity during human cytomegalovirus latency$355,828
R01 · FY2022 · AI · contact PI
Transcriptional Control of Human Cytomegalovirus Latency$369,780
R01 · FY2021 · AI · contact PI
Evading innate immunity during human cytomegalovirus latency$355,828
R01 · FY2021 · AI · contact PI
Deciphering the cell type specific control of HCMV tegument-delivered pp71 subcellular localization$194,323
R21 · FY2021 · AI · contact PI
Transcriptional Control of Human Cytomegalovirus Latency$369,780
R01 · FY2020 · AI · contact PI
Evading innate immunity during human cytomegalovirus latency$355,828
R01 · FY2020 · AI · contact PI
Deciphering the cell type specific control of HCMV tegument-delivered pp71 subcellular localization$232,500
R21 · FY2020 · AI · contact PI
Transcriptional Control of Human Cytomegalovirus Latency$369,780
R01 · FY2019 · AI · contact PI
Evading innate immunity during human cytomegalovirus latency$355,828
R01 · FY2019 · AI · contact PI
Transcriptional Control of Human Cytomegalovirus Latency$369,780
R01 · FY2018 · AI · contact PI
Role of Daxx degradation by pp71 during the Human Cytomegalovirus life cycle$367,362
R01 · FY2018 · AI · contact PI
Evading innate immunity during human cytomegalovirus latency$355,828
R01 · FY2018 · AI · contact PI
Role of Daxx degradation by pp71 during the Human Cytomegalovirus life cycle$367,362
R01 · FY2017 · AI · contact PI
Role of Daxx degradation by pp71 during the Human Cytomegalovirus life cycle$367,362
R01 · FY2016 · AI · contact PI
Role of Daxx degradation by pp71 during the Human Cytomegalovirus life cycle$371,402
R01 · FY2015 · AI · contact PI
Role of Daxx degradation by pp71 during the Human Cytomegalovirus life cycle$371,402
R01 · FY2014 · AI · contact PI
Retinoblastoma (Rb) protein pathway in human cytomegalovirus infected cells$356,014
R01 · FY2014 · AI · contact PI
Retinoblastoma (Rb) protein pathway in human cytomegalovirus infected cells$334,653
R01 · FY2013 · AI · contact PI
Retinoblastoma (Rb) protein pathway in human cytomegalovirus infected cells$356,014
R01 · FY2012 · AI · contact PI
Role of Daxx degradation by pp71 during the human cytomegalovirus life cycle$319,871
R01 · FY2012 · AI · contact PI
Retinoblastoma (Rb) protein pathway in human cytomegalovirus infected cells$359,855
R01 · FY2011 · AI · contact PI
Role of Daxx degradation by pp71 during the human cytomegalovirus life cycle$319,871
R01 · FY2011 · AI · contact PI
Retinoblastoma (Rb) protein pathway in human cytomegalovirus infected cells$410,360
R01 · FY2010 · AI · contact PI
Role of Daxx degradation by pp71 during the human cytomegalovirus life cycle$323,101
R01 · FY2010 · AI · contact PI
Role of Glycoprotein B in HCMV infection$301,169
R01 · FY2010 · AI · contact PI
Role of Daxx degradation by pp71 during the human cytomegalovirus life cycle$326,365
R01 · FY2009 · AI · contact PI
Role of Glycoprotein B in HCMV infection$304,433
R01 · FY2009 · AI · contact PI
Role of Daxx degradation by pp71 during the human cytomegalovirus life cycle$18,444
R01 · FY2009 · AI · contact PI
Role of Daxx degradation by pp71 during the human cytomegalovirus life cycle$326,365
R01 · FY2008 · AI · contact PI
Role of Glycoprotein B in HCMV infection$304,649
R01 · FY2008 · AI · contact PI
Role of Glycoprotein B in HCMV infection$310,763
R01 · FY2007 · AI · contact PI
Role and Cell Cycle Mechanisms of pp71 in HCMV Infection$294,000
R56 · FY2007 · AI · contact PI